Predicting Response to Combination Chemotherapy in Acute Myeloblasts Leukemia-a Way to Individualize Treatment-Reference-Cited by-同舟云学术

Predicting Response to Combination Chemotherapy in Acute Myeloblasts Leukemia-a Way to Individualize Treatment

Published:2009-04-24 Issue:1-6 Volume:207 Page:321-325
ISSN:0001-6101
Container-title:Acta Medica Scandinavica
language:en
Short-container-title:

Author:

Reizenstein P.,Giannoulis N. E.,Johansson N. O.

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.0954-6820.1980.tb09728.x/fullpdf

Reference8 articles.

1. Uptake and distribution of daunorubicin and daunorubicin-DNA complex in mice as studied by whole-body autoradiography and liquid chromatography;Andersson;Cancer Chemother Pharmacol,1979

2. Metabolism of daunomycin (NSC-82151) in vitro and the chemotherapeutic activity of isolated metabolites in vivo;Asbell;Cancer Chemother Rep Part,1972

3. Comparative studies on the in vitro killing of human normal and leukemic clonogenic cells (CFUc) by daunorubicin, daunorubicinol and daunorubicin-DNA complex;Beran;Cancer Chemother Pharmacol,1979

4. Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients;Eksborg;J Chromatogr,1978

5. Induction of remission with L-asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia;Gahrton;Cancer,1974

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relapse of Acute Myeloblastic Leukemia Lasting for Four Years;Acta Medica Scandinavica;2009-04-24

2. References;Acute Myelogenous Leukemia in Childhood;1990

3. Management of patients with acute non-lymphocytic leukemia who fail first cycle of induction therapy;Leukemia Research;1981-01